We are live on ! Find out more

20 hedge funds and large institutions have $193K invested in cbdMD in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.23% less ownership

Funds ownership: 11.04% → 4.81% (-6.2%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

53% less funds holding

Funds holding: 43 → 20 (-23)

69% less capital inflows, than outflows

Capital inflows: $132K | Capital outflows: $421K

92% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 25

Holders
20
Holders Change
-23
Holders Change %
-53.49%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
6
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

YCBD Hedge Fund Activity: Q2 2023 in Review

20 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q2 2023, worth a combined $193K — down 86% from $1.41M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of YCBD and 2 opened new positions — a net loss of 23 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Sentinus LLC, opening a new position worth an estimated $79K. The largest seller was Geode Capital Management, exiting entirely with an estimated $63.9K sold.

  • 20 institutional investors held cbdMD (YCBD) as of Q2 2023, down from 43 in Q1 2023.
  • Funds reported $193K of cbdMD stock for Q2 2023, down 86% quarter-over-quarter.
  • 2 funds opened new cbdMD positions in Q2 2023 and 25 closed out, a net change of -23 holders.
  • The largest cbdMD buyer in Q2 2023 was Sentinus LLC, an estimated $79K added.
  • The largest cbdMD seller in Q2 2023 was Geode Capital Management, an estimated $63.9K sold.

Based on aggregated 13F filings for Q2 2023.